A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...

A new type of drug is being tested and, if successful, it could become the first ever approved to slow or stop aging. The ...

Larger studies looking at the benefits and harms of anti-TNF compared with conventional treatment for children with active Crohn's disease are needed. Among the important outcomes to be included are ...

“As necrosis activates immune cells, potentially, uncovering the molecular drivers of anticancer therapy–induced necrosis could reveal approaches for enhancing immunotherapy efficacy.